SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Palatin (PLTN) -- Ignore unavailable to you. Want to Upgrade?


To: TradeOfTheDay who wrote (17)12/18/1997 12:19:00 PM
From: Douglas  Read Replies (1) | Respond to of 61
 
Dow Jones Newswires -- December 18, 1997
Palatin Tech 6.6M-Share Registration Statement Effective

PRINCETON, N.J. (Dow Jones)--Palatin Technologies Inc. (PLTN)
Thursday said the Securities and Exchange Commission declared effective a
registration statement covering up to 6,634,432 common shares.

The shares may be sold from time to time by selling stockholders.

The shares are outstanding, or may be issued in the future upon conversion
of series A convertible preferred stock or exercise of certain warrants.

Palatin Technologies, Princeton, N.J., develops and commercializes
products and technologies for diagnostic imaging, cancer therapy and ethical
drug development using peptide, monoclonal antibody and
radiopharmaceutical technologies.